XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 18 Months Ended
May 03, 2021
Apr. 06, 2021
Apr. 01, 2021
Apr. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2023
Dec. 31, 2021
Aug. 28, 2018
Aug. 27, 2018
Jan. 17, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common stock, par value (in dollars per share) $ 0.01       $ 0.01     $ 0.01     $ 0.01      
Price per share (in dollars per share) $ 23.00                          
Common stock, shares authorized (in shares)         1,000,000,000     1,000,000,000     1,000,000,000      
Number of options granted (in shares)               93,793            
Unrecognized share-based compensation expense         $ 63,700     $ 63,700            
Period for recognition               1 year 3 months 18 days            
Common stock, shares issued (in shares)         113,796,678     113,796,678     107,837,741      
Share based payment expense         $ 14,833 $ 25,800   $ 58,184 $ 228,461          
2021 Omnibus Incentive Plan                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common stock, shares authorized (in shares)   10,278,581                        
Award percentage increase   5.00%                        
Options grant price percent of fair market value of company stock price (at least)   100.00%                        
Number of instruments granted (in shares)   1,183,871                        
Unrecognized share-based compensation expense   $ 62,300                        
Period for recognition   4 years                        
2021 ESPP                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of shares authorized (in shares)       10,278,581                    
Award percentage of total common stock issued and outstanding (up to)       1.00%                    
Common stock, shares issued (in shares)         1,027,858     1,027,858            
Chief Executive Officer                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Accelerated vesting, percent     100.00%                      
At IPO                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Accelerated vesting, percent     60.00%                      
12months after IPO                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Accelerated vesting, percent     20.00%                      
Accelerated vesting, period     12 months                      
18 months after IPO                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Accelerated vesting, percent     20.00%                      
Accelerated vesting, period     18 months                      
Options                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of shares authorized (in shares)                       18,985,846 4,229,850 4,229,850
Period of acceleration     1 year                      
Accelerated cost             $ 195,100              
Options | Forecast                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Accelerated cost                   $ 89,900        
Options | Chief Executive Officer                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Period of acceleration     4 months                      
Restricted Stock Units (RSUs)                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of instruments granted (in shares)               1,136,607            
Restricted Stock Units (RSUs) | 2021 Omnibus Incentive Plan                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of options granted (in shares)   3,683,217                        
Elevance Health | Affiliated Entity | Privia health                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Noncontrolling interest, ownership percentage by noncontrolling owners 3.90%                          
Private Placement                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of shares issued in transaction (in shares) 4,000,000                          
Consideration received on transaction $ 92,000